“José Gabay” Course: Interview to Ricardo Lluberas

After the successful 8th edition of the ProEducar “José Gabay” Course (which took place on August 1st, 2017, at the Hilton Buenos Aires Hotel), it is time to assess its outcomes. In this case, Dr. Ricardo Lluberas, who was the SOLACI president at the time of the event, analyzed the results of the aforementioned course and SOLACI’s educational work in the promotion of interventional cardiology in Latin America.
Dr. Ricardo Lluberas.

What are your thoughts after another edition (the eighth) of the ProEducar “José Gabay” Course?

Clearly, this course marked the growth and development of ProEducar and its activities. Firstly, due to the number of participants, which has been constant over time. There is even a rising trend in that sense. This year, about 140 participants enrolled; a clear success.

 

Secondly, this growth I mentioned was reflected in the scientific level of all presentations. Highly-renowned specialists took part in the event and shared all of their expertise. That is incredibly significant and adds much value to the course, because, beyond the literature addressed, young physicians have proven to be highly inclined to listen and learn from those who are more experienced in medical practice.

 

How important is the fact that SOLACI, as an institution, fosters these events and scientific activities?

Since its foundation, SOLACI has had an essential educational role. One of its goals is, precisely, to train young professionals and educate the new generations of interventional cardiologists in Latin America. Activities such as the “José Gabay” Course are a step towards such objective.

 

As regards the future, SOLACI and the ProEducar board intend to establish and develop means for continuous training, beyond the special courses already in place.

 

How would you characterize the level of interventional cardiology in Latin America? And in Argentina?

In Latin America, levels vary according to the actual circumstances in each location. In some places, the level of interventional cardiology is extremely high in all aspects (research, clinical practice, etc.). However, some developing places somewhat justify the presence of SOLACI and its outreach to these structures. In this sense, beyond its educational function, SOLACI seeks to develop interventional cardiology in all of Latin America.

 

As regards Argentina, its level is unparalelled: interventional cardiology in Argentina has made great contributions to SOLACI, it still does. The Argentine school offers an important tradition that is passed on to new generations who continue with this development.

 

What would you say to young interventional cardiologists who have just graduated and are starting with their professional career?

I would tell them to pour their hearts and souls into it, above all else. That is what matters the most. Then, to focus on training, obviously. First comes attitude, the spiritual aspect, one’s commitment with the specialty and the patients, always within the ethical framework by which all physicians should abide. Then comes training, which is a constant throughout this process. In conclusion, I would tell them that there is no good medical practice without passion or training.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....